Research progress of spontaneous ruptured hepatocellular carcinoma

Abstract

Abstract: Spontaneously ruptured hepatocellular carcinoma (rHCC) with hemorrhage is characterized by rapid onset and progression, the pathogenesis is not clear, and liver background in rHCC patients was complicated. There is large heterogeneity between different ways of handling the survival benefit obtained, the choice of clinical decision caused great distress, so looking for some indicators or model to predict the treatment of patients with rHCC forecast is of great significance. This article is based on the existing clinical evidence, this article will review the research progress of rHCC with hemorrhage: From the rupture mechanism of hepatocellular carcinoma (HCC) are expounded of high burst tendency HCC of the operation time. Different treatments of short- and long-term survival benefit with multiple model prediction effect for the treatment of rHCC. Finally we explored the treatment of rHCC survivors.

Key words: Hepatocellular carcinoma, Spontaneously ruptured, Hepatectomy, Survival, Prediction model

Huang Xiaozhun, Wang Chunling, Liu Yibin, Li Xiaoqing, Huang Zhangkan, Xu Lin, Ni Yong, Che Xu, Bi Xinyu. Research progress of spontaneous ruptured hepatocellular carcinoma[J]. Electronic Journal of Liver Tumor, 2022, 9(2): 23-27.

References

[1] LLOVET J M, KELLEY R K, VILLANUEVA A, et al.Hepatocellular carcinoma[J]. Nat Rev Dis Primers, 2021, 7(1): 6.
[2] 徐克, 邵海波. 肝癌介入治疗新进展[J/CD]. 肝癌电子杂志, 2020, 7(3): 2-6.
[3] REN A, LUO S, JI L, et al.Peritoneal metastasis after emergency hepatectomy and delayed hepatectomy for spontaneous rupture of hepatocellular carcinoma[J]. Asian J Surg, 2019, 42(2): 464-469.
[4] XIA F, NDHLOVU E, ZHANG M, et al.Ruptured Hepatocellular Carcinoma: Current Status of Research[J]. Front Oncol, 2022, 12: 848903.
[5] AOKI T, KOKUDO N, MATSUYAMA Y, et al.Prognostic impact of spontaneous tumor rupture in patients with hepatocellular carcinoma: an analysis of 1160 cases from a nationwide survey[J]. Ann Surg, 2014, 259(3): 532-542.
[6] HIRAOKA A, KAWAMURA T, AIBIKI T, et al.Prognosis and therapy for ruptured hepatocellular carcinoma: problems with staging and treatment strategy[J]. Eur J Radiol, 2005, 84(3): 366-371.
[7] ZHU L X, WANG G S, FAN S T.Spontaneous rupture of hepatocellular carcinoma[J]. Br J Surg, 1996, 83(5): 602-607.
[8] ZHU Q, LI J, YAN J J, et al.Predictors and clinical outcomes for spontaneous rupture of hepatocellular carcinoma[J]. World J Gastroenterol, 2012, 18(48): 7302-7307.
[9] ZHU L X, WANG G S, FAN S T.Spontaneous rupture of hepatocellular carcinoma and vascular injury[J]. Arch Surg, 2001, 136(6): 682-687.
[10] MORIS D, CHAKEDIS J, SUN S H, et al.Management, outcomes, and prognostic factors of ruptured hepatocellular carcinoma: A systematic review[J]. J Surg Oncol, 2018, 117(3): 341-353.
[11] XU X, Chen C, LIU Q, et al.A Meta-analysis of TAE/TACE Versus Emergency Surgery in the Treatment of Ruptured HCC[J]. Cardiovasc Intervent Radiol, 2020, 43(9): 1263-1276.
[12] ZHANG W, ZHANG Z W, ZHANG B X, et al.Outcomes and prognostic factors of spontaneously ruptured hepatocellular carcinoma[J]. J Gastrointest Surg, 2019, 23(9): 1788-1800.
[13] 黄小准, 王春玲, 黄璋侃, 等. 急诊切除或肝动脉栓塞术后二期切除治疗肝癌自发破裂出血近远期疗效的荟萃分析[J]. 中华肝胆外科杂志, 2021, 27(11): 852-857.
[14] BUCZKOWSKI A, KIM P T, HO S G, et ak. Multidisciplinary management of ruptured hepatocellular carcinoma[J]. J Gastrointest Surg, 2006, 10(3): 379-386.
[15] HSUEH K C, FAN H L, CHEN T W, et al.Management of Spontaneously Ruptured Hepatocellular Carcinoma and Hemoperitoneum Manifested as Acute Abdomen in the Emergency Room[J]. World J Surg, 2012, 36(11): 2670-2676.
[16] OU D, YANG H, ZENG Z, et al.Comparison of the prognostic influence of emergency hepatectomy and staged hepatectomy in patients with ruptured hepatocellular carcinoma[J]. Dig Liver Dis, 2016, 48(8): 934-939.
[17] WU J J, ZHU P, ZHANG Z G, et al.Spontaneous rupture of hepatocellular carcinoma: Optimal timing of partial hepatectomy[J]. Eur J Surg Oncol, 2019, 45(10): 1887-1894.
[18] YANG H, CHEN K, WEI Y, et al.Treatment of spontaneous ruptured hepatocellular carcinoma: A single-center study[J]. Pak J Med Sci, 2014, 30(3): 472-476.
[19] ZHONG F, CHENG X S, HE K, et al.Treatment outcomes of spontaneous rupture of hepatocellular carcinoma with hemorrhagic shock: a multicenter study[J]. SpringerPlus, 2016, 5(1): 1101.
[20] ZHOU C, ZHANG C, ZU Q Q, et al.Emergency transarterial embolization followed by staged hepatectomy versus emergency hepatectomy for ruptured hepatocellular carcinoma: a single-center, propensity score matched analysis[J]. Jpn J Radiol, 2020, 38(11): 1090-1098.
[21] NGAN H, TSO W K, LAI C L, et al.The role of hepatic arterial embolization in the treatment of spontaneous rupture of hepatocellular carcinoma[J]. Clin Radiol, 1998, 53(5): 338-341.
[22] OKAZAKI M, HIGASHIHARA H, KOGANEMARU F, et al.Intraperitoneal hemorrhage from hepatocellular carcinoma: emergency chemoembolization or embolization[J]. Radiology, 1991, 180(3): 647-651.
[23] LEE K H, TSE M D, LAW M, et al.Development and validation of an imaging and clinical scoring system to predict early mortality in spontaneous ruptured hepatocellular carcinoma treated with transarterial embolization[J]. Abdom Radiol (N Y), 2019, 44(3): 903-911.
[24] FAN W Z, ZHANG Y Q, YAO W, et al. Is Emergency Transcatheter Hepatic Arterial Embolization Suitable for Spontaneously Ruptured Hepatocellular Carcinoma in Child-Pugh C Cirrhosis?[J]. J Vasc Interv Radiol, 2018, 29(3): 404.e3-412.e3.
[25] JUNDT M C, OWEN R L, THOMPSON S M, et al.MELD-Na > 16 is associated with high peri-procedural and short-term mortality in patients with ruptured hepatocellular carcinoma treated with emergent transarterial embolization[J]. Abdom Radiol (N Y), 2022, 47(1): 416-422.
[26] WU J, ZHU P, ZHANG Z, et al.A new tumor-associated antigen prognostic scoring system for spontaneous ruptured hepatocellular carcinoma after partial hepatectomy[J]. Cancer Biol Med, 2018, 15(4): 415-424.
[27] CHUA D W, KOH Y X, LIEW Y X, et al.Pre-operative predictors of early recurrence/mortality including the role of inflammatory indices in patients undergoing partial hepatectomy for spontaneously ruptured hepatocellular carcinoma[J]. J Surg Oncol, 2018, 118(8): 1227-1236.
[28] SHE W H, CHAN M Y, MA K W, et al. Alpha-Fetoprotein in Predicting Survival of Patients with Ruptured Hepatocellular Carcinoma after Resection[J]. J Invest Surg, 2021: 1-7. Online ahead of print.
[29] KAMATH P S, WIESNER R H, MALINCHOC M, et al.A model to predict survival in patients with end-stage liver disease[J]. Hepatology, 2001, 33(2): 464-470.
[30] ARROYO V, COLMENERO J.Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management[J]. J Hepatol, 2003, 38(Suppl 1): 69-89.
[31] PORCEL A, DÍAZ F, RENDÓN P, et al. Dilutional Hyponatremia in Patients With Cirrhosis and Ascites[J]. Arch Intern Med, 2002, 162(3): 323-328.
[32] FERNÁNDEZ-ESPARRACH G, SÁNCHEZ-FUEYO A, GINÈS P, et al. A prognostic model for predicting survival in cirrhosis with ascites[J]. J Hepatol, 2001, 34(1): 46-52.
[33] XIA F, ZHU P, CHEN X P, et al.Prognostic Analysis of Postoperative Survival for Ruptured Hepatocellular Carcinoma with or without Cirrhosis[J]. J Oncol, 2022: 7531452.
[34] XIA F, ZHANG Q, HUANG Z, et al.Effect of Perioperative Blood Transfusion on the Postoperative Prognosis of Ruptured Hepatocellular Carcinoma Patients With Different BCLC Stages: A Propensity Score Matching Analysis[J]. Front Surg, 2022, 9: 863790.
[35] HAMEED B, MEHTA N, SAPISOCHIN G, et al.Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria[J]. Liver Transpl, 2014, 20(8): 945-951.
[36] SHE W H, CHAN A C Y, CHEUNG T T, et al. Survival outcomes of liver transplantation for hepatocellular carcinoma in patients with normal, high and very high preoperative alpha-fetoprotein levels[J]. World J Hepatol, 2018, 10(2): 308-318.
[37] KERDSUKNIRUN J, VILAICHONE V, VILAICHONE R K.Risk Factors and Prognosis of Spontaneously Ruptured Hepatocellular Carcinoma in Thailand[J]. Asian Pac J Cancer Prev, 2018, 19(12): 3629-3634.
[38] Huang X Z, Xu L, Ma T, et al.Lenvatinib Plus Immune Checkpoint Inhibitors Improve Survival in Advanced Hepatocellular Carcinoma: A Retrospective Study[J]. Front Oncol, 2021, 11: 751159.
[39] PAN Y, WANG R, HU D, et al.Comparative safety and efficacy of molecular-targeted drugs, immune checkpoint inhibitors, hepatic arterial infusion chemotherapy and their combinations in advanced hepatocellular carcinoma: findings from advances in landmark trials[J]. Front Biosci (Landmark Ed), 2021, 26(10): 873-881.
[40] ZHENG S Z, LIU D J, SUN P, et al.Feasibility and safety of sorafenib treatment in hepatocellular carcinoma patients with spontaneous rupture[J]. World J Gastroenterol, 2014, 20(43): 16275-16281.